Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 99, Issue 2, 2013, Pages 136-144

  Pruijm, Menno ^a   Hofmann, Lucie ^a   Zanchi, Anne ^a   Maillard, Marc ^a   Forni, Valentina ^a   Muller, Marie Eve ^a   Wuerzner, Grégoire ^a   Vogt, Bruno ^a   Stuber, Matthias ^a   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

ACE inhibitor; Angiotensin receptor blocker; BOLD MRI; Furosemide; Hypertension; Renal

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALBUMIN; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; DEOXYHEMOGLOBIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; RENIN; SODIUM; SULFONYLUREA; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BOLD SIGNAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSSOVER PROCEDURE; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY CORTEX; KIDNEY MEDULLA; KIDNEY PARENCHYMA; MALE; MICROALBUMINURIA; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; SODIUM INTAKE; TISSUE OXYGENATION;

AGED; ANGIOTENSIN RECEPTOR ANTAGONISTS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FUROSEMIDE; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, THEORETICAL; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM;

EID: 84876739996     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.11.004     Document Type: Article

References (42)

1. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414(6865):782-787.
2. Qian Y., Feldman E., Pennathur S., Kretzler M., Brosius F.C. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 2008, 57(6):1439-1445.
3. Brezis M., Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 1995, 332(10):647-655.
4. Heyman S.N., Khamaisi M., Rosen S., Rosenberger C. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008, 28(6):998-1006.
5. Li L.P., Ji L., Santos E.A., Dunkle E., Pierchala L., Prasad P. Effect of nitric oxide synthase inhibition on intrarenal oxygenation as evaluated by blood oxygenation level-dependent magnetic resonance imaging. Invest Radiol 2009, 44(2):67-73.
6. Prasad P.V. Evaluation of intra-renal oxygenation by BOLD MRI. Nephron Clin Pract 2006, 103(2):c58-c65.
7. Prasad P.V., Edelman R.R., Epstein F.H. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996, 94(12):3271-3275.
8. Simon-Zoula S.C., Hofmann L., Giger A., Vogt B., Vock P., Frey F.J., et al. Non-invasive monitoring of renal oxygenation using BOLD-MRI: a reproducibility study. NMR Biomed 2006, 19(1):84-89.
9. Pohl M.A., Blumenthal S., Cordonnier D.J., De Alvaro F., Deferrari G., Eisner G., et al. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 2005, 16(10):3027-3037.
10. Khan N.A., Hemmelgarn B., Herman R.J., Bell C.M., Mahon J.L., Leiter L.A., et al. The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2-Therapy. Can J Cardiol 2009, 25(5):287-298.
11. Levy B.I. How to explain the differences between renin-angiotensin system modulators. Am J Hypertens 2005, 18(9 Pt 2):134S-141S.
12. 2 indicating a novel, potentially renoprotective action. Nephron Physiol 2003, 94(2):p39-p46.
13. Deng A., Tang T., Singh P., Wang C., Satriano J., Thomson S.C., et al. Regulation of oxygen utilization by angiotensin II in chronic kidney disease. Kidney Int 2009, 75(2):197-204.
14. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
15. O'Brien E., Asmar R., Beilin L., Imai Y., Mallion J.M., Mancia G., et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003, 21(5):821-848.
16. Tanser P.H., Campbell L.M., Carranza J., Karrash J., Toutouzas P., Watts R. Candesartan cilexetil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group. Am J Hypertens 2000, 13(2):214-218.
17. Rosei E.A., Rizzoni D., Muiesan M.L., Sleiman I., Salvetti M., Monteduro C., et al. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus. J Hypertens 2005, 23(2):435-444.
18. Pruijm M., Hofmann L., Maillard M., Tremblay S., Glatz N., Wuerzner G., et al. Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension 2010, 55(5):1116-1122.
19. Ovesen L., Boeing H., Group E. The use of biomarkers in multicentric studies with particular consideration of iodine, sodium, iron, folate and vitamin D. Eur J Clin Nutr 2002, 56(Suppl. 2):S12-S17.
20. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. Br Med J 1988, 297(6644):319-328.
21. Burnier M., Rutschmann B., Nussberger J., Versaggi J., Shahinfar S., Waeber B., et al. Salt-dependent renal effects of an angiotensin II antagonist in healthy subjects. Hypertension 1993, 22(3):339-347.
22. 2* estimation. Magn Reson Med 1998, 39(5):685-690.
23. Pedersen M., Dissing T.H., Morkenborg J., Stodkilde-Jorgensen H., Hansen L.H., Pedersen L.B., et al. Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int 2005, 67(6):2305-2312.
24. Hofmann L., Simon-Zoula S., Nowak A., Giger A., Vock P., Boesch C., et al. BOLD-MRI for the assessment of renal oxygenation in humans: acute effect of nephrotoxic xenobiotics. Kidney Int 2006, 70(1):144-150.
25. Djamali A., Sadowski E.A., Muehrer R.J., Reese S., Smavatkul C., Vidyasagar A., et al. BOLD-MRI assessment of intrarenal oxygenation and oxidative stress in patients with chronic kidney allograft dysfunction. Am J Physiol Renal Physiol 2007, 292(2):F513-F522.
26. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130(6):461-470.
27. Yin W.J., Liu F., Li X.M., Yang L., Zhao S., Huang Z.X., et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol 2012, 81(7):1426-1431.
28. Epstein F.H., Veves A., Prasad P.V. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care 2002, 25(3):575-578.
29. Economides P.A., Caselli A., Zuo C.S., Sparks C., Khaodhiar L., Katsilambros N., et al. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism 2004, 53(2):222-227.
30. 2 during water diuresis as evaluated by blood oxygenation level-dependent magnetic resonance imaging: effects of aging and cyclooxygenase inhibition. Kidney Int 1999, 55(1):294-298.
31. Wuerzner G., Chiolero A., Maillard M., Nussberger J., Brunner H.R., Burnier M. Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress. Kidney Int 2004, 65(1):238-244.
32. Juillard L., Lerman L.O., Kruger D.G., Haas J.A., Rucker B.C., Polzin J.A., et al. Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int 2004, 65(3):944-950.
33. Rognant N., Guebre-Egziabher F., Bacchetta J., Janier M., Hiba B., Langlois J.B., et al. Evolution of renal oxygen content measured by BOLD MRI downstream a chronic renal artery stenosis. Nephrol Dial Transplant 2011, 26(4):1205-1210.
34. Gomez S.I., Warner L., Haas J.A., Bolterman R.J., Textor S.C., Lerman L.O., et al. Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertension. Am J Physiol Renal Physiol 2009, 297(4):F981-F986.
35. Textor S.C., Glockner J.F., Lerman L.O., Misra S., McKusick M.A., Riederer S.J., et al. The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008, 19(4):780-788.
36. Pechere-Bertschi A., Nussberger J., Decosterd L., Armagnac C., Sissmann J., Bouroudian M., et al. Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients. J Hypertens 1998, 16(3):385-393.
37. Michaely H.J., Metzger L., Haneder S., Hansmann J., Schoenberg S.O., Attenberger U.I. Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney Int 2012, 81(7):684-689.
38. Christiansen J.S., Frandsen M., Parving H.H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981, 20(3):199-204.
39. Gloviczki M.L., Glockner J.F., Crane J.A., McKusick M.A., Misra S., Grande J.P., et al. Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 2011, 58(6):1066-1072.
40. De'Oliveira J.M., Price D.A., Fisher N.D., Allan D.R., McKnight J.A., Williams G.H., et al. Autonomy of the renin system in type II diabetes mellitus: dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997, 52(3):771-777.
41. Thelwall P.E., Taylor R., Marshall S.M. Non-invasive investigation of kidney disease in type 1 diabetes by magnetic resonance imaging. Diabetologia 2011, 54(9):2421-2429.
42. 2* changes during water diuresis. J Magn Reson Imaging 2003, 17(6):676-682.